Cholesteryl ester transfer protein (CETP) is responsible for the transfer of cholesteryl esters from antiatherogenic HDLs to proatherogenic apolipoprotein B. A deficiency of CETP is associated with increased HDL levels and decreased LDL levels, a profile that is typically antiatherogenic. Inhibition of CETP may act as potential target for antihyperlipidemic drug design. The current manuscript deals with the 3D QSAR, pharmacophore identification of some reported CETP inhibitors.
Loading....